Ann: Explanatory Webinar Presentation, page-17

You'll have to forgive me for not having seen your extensive writings previously.

After a quick search through your previous ALA posts, through the quick snipes and vague whinging, I did find this one.

https://hotcopper.com.au/threads/ann-board-changes.6782602/page-12?post_id=61884594

"Global industries are shifting around cellular therapies. Hopper and Baker have bought ALA a chip and a chair at a very large and lucrative table. ALA is not the only outfit playing this game, and they are well behind the curve compared to many competitors. But their prospects for creating shareholder value have increased enrmously"

June last year.

Fast forward 10 months, serious data coming through, serious enough that they're presenting to ACAA and have a collaboration with IMU.

Yes no doubt there's a lot of work and more than likely dilution to come. But the steps are heading in the right direction and the market looks to be agreeing and that will be the only indicator that matters.

The market can have an extremely short memory, it doesn't care for an individuals emotions.